{
  "id": 5147088,
  "title": "Novartis CAR-T deaths raise questions over acceptable autoimmune risk",
  "url": "https://urgent.news/2026/09/02/novartis-car-t-deaths-raise-questions-over-acceptable-autoimmune-risk",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-02T18:48:44.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/novartis-car-t-deaths-raise-questions-over-acceptable-autoimmune-risk/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Many researchers believe cancer cell therapies called CAR-Ts could shift the treatment paradigm for patients with autoimmune disease. But three recently disclosed deaths in Novartis’ clinical trials serve as a stark reminder that the modality ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts",
        "url": "https://urgent.news/2026/09/02/autoimmune-car-t-faces-tough-questions-after-novartis-bristol-myers",
        "published": "2026-09-02T16:32:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}